Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,026 public trials 2,026 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

A Trial in Patients With Diffuse Large-B-cell Lymphoma Comparing Pixantrone Against Doxorubicin

NCT00268853

Conditions
Diffuse Large-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Bay Medical Oncology & Hematology Concord, California, United States
  • Hazel Hawkins Hospital, Dept. of Medical Oncology Hollister, California, United States
  • UCSD Moore's Cancer Center-Blood & Marrow Transplantation Division La Jolla, California, United States
  • Loma Linda University Medical Center Loma Linda, California, United States
View all 75 locations
View Trial Details
Completed

Study of Brentuximab Vedotin (SGN-35) in Pediatric Participants With Relapsed or Refractory (r/r) Systemic Anaplastic Large-Cell Lymphoma or Hodgkin Lymphoma

NCT01492088

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Hodgkin Disease, +15 more
Locations
  • Aurora, Colorado, United States
  • Kansas City, Missouri, United States
  • New York, United States
  • Houston, Texas, United States
View all 18 locations
View Trial Details
Completed

Carfilzomib, Rituximab, and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Lymphoma

NCT02073097

Conditions
Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations
  • Roswell Park Comprehensive Cancer Center Buffalo, New York, United States
  • University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
  • Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States
View Trial Details
Completed

A Study to Compare Daratumumab, Bortezomib, and Dexamethasone (DVd) vs Bortezomib and Dexamethasone (Vd) in Chinese Participants With Relapsed or Refractory Multiple Myeloma

NCT03234972

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Peking Union Medical College Hospital Beijing, China
  • Peking University First Hospital Beijing, China
  • Peking University People s Hospital Beijing, China
  • Peking University Third Hospital Beijing, China
View all 27 locations
View Trial Details
Completed

Apremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo: an Analysis of Clinical Safety and Efficacy

NCT03721172

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +15 more
Locations
  • Total Skin & Beauty Dermatology Center Birmingham, Alabama, United States
  • Johnson Dermatology Clinic Fort Smith, Arkansas, United States
  • Northwest Arkansas Clinical Trials Center, PLLC / Hull Dermatology Rogers, Arkansas, United States
  • Dermatology Research Associates Los Angeles, California, United States
View all 64 locations
View Trial Details
Completed

Blinatumomab in Adults With Relapsed/Refractory Philadelphia Positive B-precursor Acute Lymphoblastic Leukemia

NCT02000427

Conditions
Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
Locations
  • Research Site Duarte, California, United States
  • Research Site La Jolla, California, United States
  • Research Site Atlanta, Georgia, United States
  • Research Site Rochester, Minnesota, United States
View all 22 locations
View Trial Details

Related conditions